leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 04:12:45 - browse：82914

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Illinois Supreme Court finds assault weapons ban constitutional

leisure time

focus

WSS

Patients, digital health players weigh in on FTC's data privacy plan

HHS suspends federal funding for EcoHealth Alliance

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Fertility clinic egg and embryo storage is a disaster

Biogen’s boardroom scandal saddles CEO with first crisis

Fertility clinic egg and embryo storage is a disaster

hotspot

leisure time

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Psychedelics group wrestles with new pharma identity

Oak Street deal isn't the answer to health care's woes

Novavax promises a turnaround & Lilly roils the obesity market

Aspartame and sugar

How to save PrEP access — and even expand it

Abbott's new stent may help patients with peripheral artery disease

Anesthesiologist group: stop taking Ozempic before surgery

The White House hikes tariffs on plastic syringes made in China

leisure time

Obesity drug from Roche shows promise in early study

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Dozens dead from Maui wildfires: What we know about the victims

STAT series 'Denied by AI' wins major journalism prizes

The United States must get value

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

leisure time

hotspot

focus

focus